UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis

Frontiers in immunology, 2023-10, Vol.14, p.1265511-1265511

2023

Link zum Volltext

Verfügbarkeit prüfen

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

The Lancet infectious diseases, 2019-03, Vol.19 (3), p.298-307

2019

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism

mBio, 2021-12, Vol.12 (6), p.e0176621-e0176621

2021

Link zum Volltext

Verfügbarkeit prüfen

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis

PloS one, 2015-09, Vol.10 (9), p.e0139017-e0139017

2015

Link zum Volltext

Verfügbarkeit prüfen

Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes

Frontiers in immunology, 2017-05, Vol.8, p.542-542

2017

Link zum Volltext

Verfügbarkeit prüfen

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis

PloS one, 2015-04, Vol.10 (4), p.e0123655-e0123655

2015

Link zum Volltext

Verfügbarkeit prüfen

Primary central nervous system lymphoma presenting as multiple space-occupying lesions in advanced human immunodeficiency virus infection

SA journal of radiology, 2017-11, Vol.21 (2), p.1-6

2017

Link zum Volltext

Verfügbarkeit prüfen

A model for analysis of antibiotic usage in low-income settings

Journal of antimicrobial chemotherapy, 2023-08, Vol.78 (8), p.2015-2018

2023

Link zum Volltext

Verfügbarkeit prüfen

Unusual complication and successful high-dose chemotherapy treatment of advanced Burkitt’s lymphoma in an adult HIV-positive patient

SA journal of radiology, 2017-11, Vol.21 (2), p.1-4

2017

Link zum Volltext

Verfügbarkeit prüfen

Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

AIDS (London), 2011-08, Vol.25 (13), p.1671-1673

2011

Link zum Volltext

Verfügbarkeit prüfen

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis

Clinical infectious diseases, 2017-05, Vol.64 (10), p.1350-1359

2017

Link zum Volltext

Verfügbarkeit prüfen

Understanding and intervening in HIV-associated tuberculosis

Clinical medicine (London, England), 2015-12, Vol.15 (6), p.s43-s49

2015

Link zum Volltext

Verfügbarkeit prüfen

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

Antimicrobial agents and chemotherapy, 2016-10, Vol.60 (10), p.6050-6059

2016

Link zum Volltext

Verfügbarkeit prüfen

Assessment of treatment response in tuberculosis

Expert review of respiratory medicine, 2016-06, Vol.10 (6), p.643-654

2016

Link zum Volltext

Verfügbarkeit prüfen

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence

The Journal of infectious diseases, 2017-09, Vol.216 (6), p.632-640

2017

Link zum Volltext

Verfügbarkeit prüfen

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?

Journal of the International AIDS Society, 2019-07, Vol.22 (7), p.e25333-n/a

2019

Link zum Volltext

Verfügbarkeit prüfen

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Clinical pharmacokinetics, 2019-06, Vol.58 (6), p.747-766

2019

Link zum Volltext

Verfügbarkeit prüfen

Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study

The European respiratory journal, 2022-04, Vol.59 (4), p.2100905

2022

Link zum Volltext

Verfügbarkeit prüfen

Utility of Second-Generation Line Probe Assay (Hain MTBDR plus ) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response

Journal of clinical microbiology, 2017-05, Vol.55 (5), p.1508-1515

2017

Link zum Volltext

Verfügbarkeit prüfen

Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV

The Journal of infection, 2013-01, Vol.66 (1), p.103-106

2013

Link zum Volltext

Verfügbarkeit prüfen

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multi-centre cohort study

The Lancet infectious diseases, 2019-02, Vol.19 (3), p.298-307

2019

Link zum Volltext

Verfügbarkeit prüfen

Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapy

Antiviral therapy, 2015-01, Vol.20 (2), p.157-163

2015

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis

The Lancet. Microbe, 2021-08, Vol.2 (8), p.e375-e385

2021

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis

The Lancet. Microbe, 2021-08, Vol.2 (8), p.e375

2021

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 30

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(27)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(28)
Berichte
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Humans
(17)
Life Sciences & Biomedicine
(17)
Tuberculosis
(12)
Hiv
(11)
Adult
(9)
Human Immunodeficiency Virus
(9)
Infectious Diseases
(9)
Male
(9)
Antitubercular Agents - Therapeutic Use
(8)
Drug Resistance
(7)
Female
(7)
Hiv Infections - Drug Therapy
(7)
Hiv Infections - Complications
(6)
Immunology
(6)
Microbiology
(6)
Mycobacterium Tuberculosis - Drug Effects
(6)
Treatment Outcome
(6)
Tuberculosis - Drug Therapy
(6)
Middle Aged
(5)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Immunomodulatory properties of morphine and the hypothesised role of long-term opioid use in the immunopathogenesis of tuberculosis

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multicentre cohort study

Transcriptomic Characterization of Tuberculous Sputum Reveals a Host Warburg Effect and Microbial Cholesterol Catabolism

Risk Factors for Acquired Rifamycin and Isoniazid Resistance: A Systematic Review and Meta-Analysis

Mycobacterium tuberculosis Induction of Heme Oxygenase-1 Expression Is Dependent on Oxidative Stress and Reflects Treatment Outcomes

High frequency of resistance, lack of clinical benefit, and poor outcomes in capreomycin treated South African patients with extensively drug-resistant tuberculosis

Primary central nervous system lymphoma presenting as multiple space-occupying lesions in advanced human immunodeficiency virus infection

A model for analysis of antibiotic usage in low-income settings

Unusual complication and successful high-dose chemotherapy treatment of advanced Burkitt’s lymphoma in an adult HIV-positive patient

Ritonavir-boosted atazanavir exposure is associated with an increased rate of renal stones compared with efavirenz, ritonavir-boosted lopinavir and ritonavir-boosted darunavir

Concentration-Dependent Antagonism and Culture Conversion in Pulmonary Tuberculosis

Understanding and intervening in HIV-associated tuberculosis

HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

Assessment of treatment response in tuberculosis

Low Frequency of Acquired Isoniazid and Rifampicin Resistance in Rifampicin-Susceptible Pulmonary Tuberculosis in a Setting of High HIV-1 Infection and Tuberculosis Coprevalence

Global access of rifabutin for the treatment of tuberculosis – why should we prioritize this?

A Systematic Review on the Effect of HIV Infection on the Pharmacokinetics of First-Line Tuberculosis Drugs

Baseline IL-6 is a biomarker for unfavourable tuberculosis treatment outcomes: a multisite discovery and validation study

Baseline IL-6 is a biomarker for unfavorable tuberculosis treatment outcomes: a multi-site discovery and validation study

Utility of Second-Generation Line Probe Assay (Hain MTBDR plus ) Directly on 2-Month Sputum Specimens for Monitoring Tuberculosis Treatment Response

Chronic Hepatitis E as a cause for cryptogenic cirrhosis in HIV

Drug susceptibility testing and mortality in patients treated for tuberculosis in high-burden countries: a multi-centre cohort study

Switching safely: pharmacokinetics, efficacy and safety of switching efavirenz to maraviroc twice daily in patients on suppressive antiretroviral therapy

Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis

Inflammatory profile of patients with tuberculosis with or without HIV-1 co-infection: a prospective cohort study and immunological network analysis

Suchergebnisse filtern